🔴 Femasys is trading 6.7% down amid broad-market pressure

Femasys is trading at $1.54, down -6.67%, amid broad-market pressure rather than a clearly identified company catalyst.

• No new company-specific announcement for October 22 was identified; the recent SandsRx partnership was announced October 20.
• The supplied market context shows the Nasdaq down 2.19% and the S&P 500 down 1.38%. Rising oil prices and renewed Middle East tensions are weighing on broader sentiment.